Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0267|227|3|132-138

ISSN： 0030-3755

Source： Ophthalmologica, Vol.227, Iss.3, 2011-12, pp. : 132-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 216-222

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab versus Isovolemic Hemodilution in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized, Multicenter Trial

By  

Ophthalmologica, Vol. 233, Iss. 1, 2014-12 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-11 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12-month Follow-Up and Prognostic Factors

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 207-215

Karger

Access to resources Recommend Favorite